We are live on
!
Find out more
C
Consulta Portfolio holdings
AUM
$2.77B
1-Year Est. Return
3.62%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
+3.62%
3 Year Est. Return
+30.69%
5 Year Est. Return
+30.14%
10 Year Est. Return
+206.35%
AUM
$1.52B
AUM Growth
+$127M
(+9.1%)
Cap. Flow
+$8.94M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
83.74%
Holding
14
New
1
Increased
2
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$48.7M |
| 2 |
HCA Healthcare
HCA
|
+$37.1M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$40M |
| 2 |
Visa
V
|
+$24.6M |
| 3 |
JPMorgan Chase
JPM
|
+$22.7M |
| 4 |
Danaher
DHR
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.3% |
| 2 | Financials | 20.53% |
| 3 | Communication Services | 19.44% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 10.49% |
Similar funds
HCM
BGM
SIM
JHP
DJSG
CAAS
CCM
FFA
Consulta's Q4 2023 Portfolio in Review
As of Q4 2023, Consulta held 14 positions worth $1.52B, up 9.1% from $1.39B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Consulta's Q4 2023 filing shows 1 new, 2 increased and 4 reduced positions. Its largest new stake was Starbucks: 500,000 shares worth $48M. The largest sale was UnitedHealth, an estimated $40M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.
- Consulta's largest Q4 2023 buy was Starbucks: 500,000 shares worth $48M.
- Consulta added most to HCA Healthcare in Q4 2023, an estimated $37.1M increase.
- Consulta's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $40M.
- Consulta's ten largest holdings make up 84% of its $1.52B portfolio in Q4 2023.
- Consulta opened 1 new position and closed 0 in Q4 2023.
- Consulta's portfolio value rose 9.1% quarter-over-quarter to $1.52B.
Based on Consulta's 13F filing for Q4 2023, filed 14 Feb 2024.